INTERNATIONAL PATENT: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, UNIVERSITY OF CHICAGO, LEIDOS BIOMEDICAL RESEARCH, INC., SCHRODINGER, INC., CURIA GLOBAL, INC., PATNAIK, SAMARJIT, SHRIMP, JONATHAN HAROLD, SUN, HONGMAO, MARUGAN, JUAN JOSE, KONG, KE, LIU, LI, HALL, MATTHEW D., FLINT, ANDREW JOHN, SHEN, MIN, HANSON, QUINLIN M., CHENG, CHIH-CHIEN, YANG, TAE GYUN, MOORE, WILLIAM JAY, HEIDE, JANNA, LENGYEL, ERNST, JANISZEWSKI, JOHN STEPHEN FILES APPLICATION FOR "TRIAZOLONE INHIBITORS OF NICOTINAMIDE N-METHYLTRANSFERASE AND THEIR THERAPEUTIC USES"

GENEVA, June 25 -- THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (National Institutes of Health, OTT6701 Rockledge Drive, Suite 700MSC 7788Bethesda, Maryland 20892-7788), UNIVERSITY OF CHICAGO (5801 South Ellis AvenueChicago, Illinois 60637), LEIDOS BIOMEDICAL RESEARCH, INC. (1050 Boyles StreetFrederick, Maryland 21702), SCHRODINGER, INC. (1540 Broadway, 24th FloorNew York, New York 10036), CURIA GLOBAL, INC. (24 Corporate CircleAlbany, NY 12203), PATNAIK, Samarjit (OTT, National Institutes of Health6701 Rockledge Drive, Suite 700, MSC 7788Bethesda, Maryland 20892-7788), SHRIMP, Jonathan Harold (OTT, National Institutes of Health6701 Rockledge Drive, Suite 700, MSC 7788Bethesda, Maryl...